SomaLogic was founded in 2000 by Larry Gold, with the long-term goal of transforming health care by empowering individuals around the world to actively optimize and maintain their health. Although the first draft of the human genome was also announced that year, SomaLogic embarked on a different path than everyone else, focusing instead on the much harder challenge of measuring changes in the body’s proteins in relation to disease and health. We believed then — and know today — that wide and deep protein measurement can move the idea of precision health from rhetoric to reality.
It took almost two decades of innovative research and investment to reach that goal, but today SomaLogic operates the SomaScan® Platform, a new technology that makes protein measurement as straightforward as DNA measurement. In addition to providing this powerful tool to others, we use the SomaScan Platform to uncover a deeper understanding of the real-time molecular bases of health and disease than is possible through genomic or other protein technologies.
From these complex protein measurements, we computationally extract meaningful and precise health information, which we offer to individuals and their health providers in the form of a growing menu of SomaSignal™ tests. These tests are available through select physician practices in the Denver, Colorado area. Please contact us for more information.
Today, SomaLogic has approximately 200 employees worldwide. It is headquartered in Boulder, Colorado.
At first glance, SomaLogic’s logomark looks like the letter “S,” referencing the company’s name. But its meaning is much deeper. The overall hexagonal shape of the logomark is inspired by the first solved crystal structure of a proprietary Slow Off-rate Modified Aptamer (SOMAmer®) reagent bound to its target protein, specifically a hexagonal “benzyl group” of a SOMAmer reagent inserted into a protein pocket (zoomed view at right). The logomark also represents part of an “alpha helix,” a structural feature found in most proteins.